إعلان
إعلان

PDSB

PDSB logo

PDS Biotechnology Corporation Common Stock

1.07
USD
برعاية
+0.07
+7.42%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

1.05

-0.02
-1.59%

تقارير أرباح PDSB

النسبة الإيجابية المفاجئة

PDSB تفوق 25 من 36 آخر التقديرات.

69%

التقرير التالي

بيانات التقرير القادم
٢٥ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-9.52%

PDS Biotechnology Corporation Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, PDSB reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 12.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an زيادة of 0.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, PDS Biotechnology Corporation Common Stock reported EPS of -$0.19, beating estimates by 12.68%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.33%, changed from $0.96 before the earnings release to $0.84 the day after.
The next earning report is scheduled for ٢٥ مارس ٢٠٢٦.
Based on 4 المحللين, PDS Biotechnology Corporation Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان